FDA Inspection 1249413 — Marta J. Chelminska, M.D., Ph.D.
The FDA completed an inspection of Marta J. Chelminska, M.D., Ph.D. on Aug 30, 2024 in Gdansk. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 30, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gdansk (Poland)
Additional Details
Clinical Investigator (CI)